Youssef Irini, Kamran Haroon, Yacoub Mena, Patel Nirav, Goulbourne Clive, Kumar Shweta, Kane Jesse, Hoffner Haley, Salifu Moro, McFarlane Samy I
Department of Medicine, Divisions of Endocrinology, Cardiology and Renal Medicine, State University of New York, Downstate Medical Center, Brooklyn, NY, USA.
Department of Cardiology, Northside Hospital, St. Petersburg FL, USA.
J Sleep Disord Ther. 2018;7(1). doi: 10.4172/2167-0277.1000282. Epub 2018 Feb 12.
To conducted a meta-analysis assessing the relationship between Obstructive Sleep Apnea (OSA) and the risk of Atrial Fibrillation (AF).
We searched PUBMED, Medline, and Cochrane Library using the keywords "atrial fibrillation", "obstructive sleep apnea" and "sleep disordered breathing (SDB)". All subjects included had established diagnosis of OSA/SDB. We then compared the occurrence of AF versus no AF. Analysis done with Comprehensive Meta-Analysis package V3 (Biostat, USA).
A total of 579 results were generated. Duplicates were removed and 372 records were excluded based on irrelevant abstracts, titles, study design not consistent with the stated outcome, or full-text unavailable. Twelve studies meeting the inclusion criteria were reviewed in full-text; 2 of these articles were eventually removed due to unconfirmed OSA diagnostic modality, and one was also removed based on a control group inconsistent with the other studies. Therefore, a total of 9 studies were included (n=19,837). Sample sizes ranged from n=160 patients to n=6841 patients. The risk of AF was found to be higher among OSA/SDB versus control group (OR; 2.120, C.I: 1.845-2.436, Z; 10.598 p: <0.001). The heterogeneity observed for the pooled analysis was Q-value; 22.487 df (Q); 8 P-value; 0.004, I-squared; 64.424 Tau2; 0.098, suggesting appropriate study selection and moderate heterogeneity.
OSA/SDB is strongly associated with AFib confirming the notion that OSA/SDB populations are high risk for development of AF. Prospective studies are needed to ascertain the effect of the treatment of OSA/SDB for the prevention of AF, a growing health burden with serious consequences.
进行一项荟萃分析,评估阻塞性睡眠呼吸暂停(OSA)与心房颤动(AF)风险之间的关系。
我们使用关键词“心房颤动”、“阻塞性睡眠呼吸暂停”和“睡眠呼吸障碍(SDB)”在PUBMED、Medline和Cochrane图书馆进行检索。纳入的所有受试者均已确诊为OSA/SDB。然后我们比较了AF的发生情况与未发生AF的情况。使用综合荟萃分析软件包V3(美国Biostat公司)进行分析。
共产生579条结果。去除重复项后,基于不相关的摘要、标题、与所述结果不一致的研究设计或无全文,排除了372条记录。对符合纳入标准的12项研究进行了全文审查;其中2篇文章最终因OSA诊断方式未得到证实而被剔除,1篇文章也因对照组与其他研究不一致而被剔除。因此,共纳入9项研究(n = 19,837)。样本量从n = 160例患者到n = 6841例患者不等。发现OSA/SDB组发生AF的风险高于对照组(比值比;2.120,置信区间:1.845 - 至2.436,Z值;10.598,P值;<0.001)。汇总分析观察到的异质性为Q值;22.487,自由度(Q);8,P值;0.004,I²;64.424,Tau²;0.098,表明研究选择适当且异质性中等。
OSA/SDB与房颤密切相关,证实了OSA/SDB人群发生房颤的风险较高这一观点。需要进行前瞻性研究以确定治疗OSA/SDB对预防房颤的效果,房颤作为一种日益严重的健康负担,会带来严重后果。